Is it safe to drop CD4+ monitoring among virologically suppressed patients: A cohort evaluation from Khayelitsha, South Africa

AIDS

Volumn 28, Issue 14, 2014, Pages 2003-2005

  Ford, Nathan ^a   Stinson, Kathryn ^b,c   Davies, Mary Ann ^c   Cox, Vivian ^b   Patten, Gabriela ^b   Cragg, Carol ^d   Van Cutsem, Gilles ^b,c   Boulle, Andrew ^c  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b MÉDECINS SANS FRONTIÈRES   (Switzerland)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d WESTERN CAPE DEPARTMENT OF HEALTH   (South Africa)

Author keywords

Africa; Antiretroviral therapy; Treatment monitoring; Viral load

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ PLUS LAMIVUDINE PLUS STAVUDINE; EFAVIRENZ PLUS LAMIVUDINE PLUS ZIDOVUDINE; STAVUDINE; UNCLASSIFIED DRUG; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

BIOLOGICAL MONITORING; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; COMBINATION CHEMOTHERAPY; HEALTH CARE DELIVERY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMUNE STATUS; IMMUNOSUPPRESSIVE TREATMENT; INTERNATIONAL COOPERATION; NOTE; OPPORTUNISTIC INFECTION; PATIENT SAFETY; PRIORITY JOURNAL; SOUTH AFRICA; VIRUS LOAD; AMBULATORY CARE; COHORT ANALYSIS; HIV INFECTIONS; HOSPITAL INFORMATION SYSTEM; IMMUNOLOGY; PRACTICE GUIDELINE; PROCEDURES;

AMBULATORY CARE; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; HIV INFECTIONS; HUMANS; POINT-OF-CARE SYSTEMS; PRACTICE GUIDELINES AS TOPIC; SOUTH AFRICA; VIRAL LOAD;

EID: 84906934039     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000406     Document Type: Note

References (15)

1. Guidelines for the use of antiretroviral agents in HIV-infected adults and, adolescents. Department of Health and Human Services and Henry J Kaiser Family Foundation. MMWR Recomm Rep 1998; 47 ((RR-5)): 43-82.
2. Harrigan R. Measuring viral load in the clinical setting. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 10 (Suppl 1): S34-S40.
3. Rutherford G, Anglemyer A, Easterbrook P, Horvath T, Vitoria M, Penazzato M, Doherty M. Predicting treatment failure in adults and children on antiretroviral therapy: a systematic review of the performance characteristics of the World Health Organization's 2010 criteria for virological failure. AIDS (Suppl 2): 2014: S161-S169.
4. Vitoria M, Vella S, Ford N. Scaling up antiretroviral therapy in resource-limited settings: adapting guidance to meet the challenges. Curr Opin HIV AIDS 2013; 8: 12-18.
5. Technical and operational considerations for implementing HIV viral load testing. Interim technical update. Geneva, Switzerland: CDC, PEPFAR, USAID, WHO, the Global Fund to Fight AIDS, Tuberculosis and Malaria and the African Society for Laboratory Medicine; July 2014.
6. Anon. March 2014 supplement to the 2013 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach. Geneva, Switzerland: World Health Organization, March 2014.
7. Gale HB, Gitterman SR, Hoffman HJ, Gordin FM, Benator DA, Labriola AM, Kan VL. Is frequent CD4R T-lymphocyte count monitoring necessary for persons with counts >U300cells/muL and HIV-1 suppression? Clin Infect Dis 2013; 56: 1340-1343.
8. Girard PM, Nelson M, Mohammed P, Hill A, van Delft Y, Moecklinghoff C. Can we stop CD4 testing in patients with HIV-1 RNA suppression on antiretroviral treatment? Analysis of the ARTEMIS trial. AIDS 2013; 27: 2759-2763.
9. Boulle A, Van Cutsem G, Hilderbrand K, Cragg C, Abrahams M, Mathee S, et al. Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha South Africa. AIDS 2010; 24: 563-572.
10. Luque-Fernandez MA, Van Cutsem G, Goemaere E, Hilderbrand K, Schomaker M, Mantangana N, et al. Effectiveness of patient adherence groups as a model of care for stable patients on antiretroviral therapy in Khayelitsha, Cape Town, South Africa. PLoS One 2013; 8: e56088.
11. Stinson K, Goemaere E, Coetzee D, et al. 12-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa (Poster). 17th International Conference on HIV and STIs in Africa, 7-11 December 2013. Cape Town, South Africa; 2013.
12. Meintjes G, Maartens G, Boulle A, Conradie F, Goemaere E, Hefer E, et al. Guidelines for antiretroviral therapy in adults by the Southern African HIV Clinicians Society. SAJHIVMED 2012; 13: 114-133.
13. Anon. Panel on antiretroviral guidelines for adults and adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services, 2014. http://aidsinfo.nih. gov/ContentFiles/Adultand AdolescentGL.pdf.
14. Gilks CF, Crowley S, Ekpini R, Gove S, Perriens J, Souteyrand Y, et al. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet 2006; 368: 505-510.
15. Aberg JA, Gallant JE, Ghanem KG, Emmanuel P, Zingman BS, Horberg MA. Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2013; 58: 1-10.